Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Mar, 2006 | Pubmed ID: 16505437